PLK1 and cancer: Besides, we found that the cancers with higher PLK1 expression levels had significantly higher frequency of TP53 mutations than the cancers with lower PLK1 expression levels in 12 cancer types (Fisher's exact test, FDR<0.05) (Figure 8(b)), suggesting that the PLK1 upregulation positively correlates with the prevalence of TP53 mutations.